Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| PCRX | PRESS-RELEASE | neutral | 1/10 | Pacira BioSciences announced it will report its Q2 2026 results on August 4, 2026. | Jul 22, 2026 |
| MNPR | PRESS-RELEASE | bullish | 7/10 | Monopar Therapeutics initiated a rolling NDA submission to the FDA for ALXN1840 (tiomolibdate choline), a first-in-class | Jul 22, 2026 |
| LBRX | PRESS-RELEASE | bullish | 6/10 | LB Pharmaceuticals announced that its pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia is enrolling faster than e | Jul 22, 2026 |
| TRU | PRESS-RELEASE | neutral | 2/10 | TransUnion released its Q2 2026 Canada Consumer Pulse Study, a survey on Canadian household financial sentiment and beha | Jul 22, 2026 |
| RGEN | PRESS-RELEASE | bullish | 7/10 | Repligen acquires BioLife Solutions for $1.5B (64% stock, 36% cash), paying $31.00/share, a 24% premium to the 90-day VW | Jul 22, 2026 |
| IQMX | PRESS-RELEASE | neutral | 1/10 | IQM Quantum Computers Oyj announced it will report its Q2 2026 results on August 4, 2026. | Jul 22, 2026 |
| GNTA | PRESS-RELEASE | neutral | 4/10 | Genenta Science (GNTA) reported FY2025 results for its 19%-owned affiliate Sòphia HT, showing 29.3% sales growth to €7.1 | Jul 22, 2026 |
| VVY | PRESS-RELEASE | neutral | 1/10 | Vivoryon Therapeutics N.V. announced it will report its full-year 2026 results on August 6, 2026. | Jul 22, 2026 |
| DYN | PRESS-RELEASE | bearish | 6/10 | Dyne Therapeutics priced an upsized underwritten public offering of 18.3 million shares at $20.50 per share, raising gro | Jul 21, 2026 |
| AIRJ | PRESS-RELEASE | bullish | 6/10 | AirJoule Technologies announced an initial deployment and exclusive sales agreement with Kubota Corporation for its wate | Jul 21, 2026 |
| NSC | PRESS-RELEASE | neutral | 2/10 | Norfolk Southern declared a quarterly dividend of $1.35 per share, payable August 20, 2026, to shareholders of record on | Jul 21, 2026 |
| TOP | PRESS-RELEASE | bearish | 7/10 | TOP Financial Group announced that all outstanding warrants to purchase up to 428,862,444 Class A ordinary shares were e | Jul 21, 2026 |
| BIP | PRESS-RELEASE | neutral | 5/10 | Brookfield Infrastructure Partners (BIP) and Brookfield Infrastructure Corporation (BIPC) announced a plan to simplify t | Jul 21, 2026 |
| BEP | PRESS-RELEASE | bullish | 6/10 | Brookfield Renewable announced plans to simplify its corporate structure by converting BEP (limited partnership) and BEP | Jul 21, 2026 |
| FULT | PRESS-RELEASE | neutral | 2/10 | Fulton Financial Corporation announced the appointment of David S. Schulz to its board of directors, effective September | Jul 21, 2026 |
| ACRE | PRESS-RELEASE | neutral | 1/10 | Ares Commercial Real Estate Corporation announced it will report its Q2 2026 results on August 4, 2026. | Jul 21, 2026 |
| EQT | PRESS-RELEASE | mixed | 6/10 | EQT reported Q2 2026 GAAP EPS of $0.34, missing the $0.42 consensus by 19%, and GAAP revenue of $1.81B, missing the $1.8 | Jul 21, 2026 |
| CPK | PRESS-RELEASE | neutral | 1/10 | Chesapeake Utilities Corporation announced it will host a conference call on August 7, 2026 to discuss its Q2 2026 resul | Jul 21, 2026 |
| HAFC | PRESS-RELEASE | neutral | 4/10 | Hanmi Bank (HAFC) reported Q2 2026 EPS of $0.79, a 2.9% beat vs. consensus of $0.77, with net income rising 4.2% sequent | Jul 21, 2026 |
| NBHC | PRESS-RELEASE | bearish | 6/10 | NBHC reported Q2 2026 GAAP EPS of $0.58, a 28.4% miss vs consensus of $0.81, and revenue of $129.1M missed the $135.3M e | Jul 21, 2026 |
| ORRF | PRESS-RELEASE | neutral | 5/10 | Orrstown Financial Services reported Q2 2026 EPS of $1.09, a 6.2% beat vs consensus of $1.03, driven by a lower effectiv | Jul 21, 2026 |
| RRC | PRESS-RELEASE | bullish | 6/10 | Range Resources Q2 2026 GAAP EPS of $0.83 crushed consensus $0.65 (+27.7%) on revenue of $834M vs $749.2M (+11.3%), driv | Jul 21, 2026 |
| OZK | PRESS-RELEASE | bearish | 5/10 | Bank OZK reported Q2 2026 EPS of $1.49, a 5.7% YoY decline and a miss versus the $1.48 consensus estimate. Net income fe | Jul 21, 2026 |
| LRN | PRESS-RELEASE | neutral | 1/10 | Stride, Inc. announced it will report its fiscal Q4 2026 results on August 4, 2026. | Jul 21, 2026 |
| SRTA | PRESS-RELEASE | neutral | 1/10 | Strata Critical Medical, Inc announced it will host a conference call on August 4, 2026 to discuss its Q2 2026 results. | Jul 21, 2026 |
| WFRD | PRESS-RELEASE | bearish | 7/10 | Weatherford reported Q2 2026 GAAP diluted EPS of $0.55, missing the $0.90 consensus by 38.9%, while revenue of $1,105M b | Jul 21, 2026 |
| NYAX | PRESS-RELEASE | neutral | 1/10 | Nayax Ltd. announced it will report its Q2 2026 results on August 10, 2026. | Jul 21, 2026 |
| ACRV | PRESS-RELEASE | neutral | 3/10 | Acrivon Therapeutics announced presentations at the AACR D3 conference highlighting preclinical and early clinical data | Jul 21, 2026 |
| TLX | PRESS-RELEASE | bullish | 5/10 | Telix announced peer-reviewed publication of ProstACT SELECT Phase 1 results in Cancers, confirming that 68Ga-PSMA-PET i | Jul 21, 2026 |
| RRX | PRESS-RELEASE | neutral | 2/10 | Regal Rexnord declared a regular quarterly dividend of $0.35 per share, payable in October 2026. This is a routine capit | Jul 21, 2026 |